Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus - Nita, S. Kioko Ono; Kato, Naoya; Shiratori, Yasushi; Carrilho, Flair José; Omata, Masao (Antimicrobial Agents and Chemoterapy, 2002)